| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 烟台正海生物科技股份有限公司成立于2003年，于2017年5月16日成功上市（股票代码：300653），是国家重点研发计划承担单位，国家“863”计划承担单位，高新技术企业。公司立足再生医学领域，处于“十四五”战略重点发展产业，通过ISO13485/ISO9001质量管理体系认证，公司设有山东省医用再生修复材料工程技术研究中心、山东省企业技术中心、生物再生材料山东省工程研究中心等高规格再生医学材料研发平台。 公司注重科技创新，产品研发管线丰富，竞争优势明显。申报国际国内专利90余项，核心专利先后荣获山东省专利奖一等奖、中国专利优秀奖。依托核心脱细胞技术，产品可实现调节、引导、促进人体自身组织细胞再生的功能。已上市产品有口腔修复膜、可吸收硬脑（脊）膜补片、活性生物骨、皮肤修复膜、骨修复材料、外科用填塞海绵、自酸蚀粘接剂。临床上广泛应用于口腔科、头颈外科、神经外科、耳鼻喉科等多个领域，赢得了数以百万计医生和患者的信赖与支持。 公司先后承担国家及省市各级科技发展项目90余项，获批国家重点研发计划、国家“863”计划、国家火炬计划、国家专精特新“小巨人”企业、国家知识产权示范企业、工业企业知识产权运用试点企业、山东省自主创新重大专项、山东省制造业单项冠军、山东省技术创新示范企业、山东省质量标杆企业、山东省新材料领军企业50强、山东省隐形冠军企业、山东省知名品牌、山东省优质品牌、各级技术发明奖、科技进步奖等诸多荣誉，是中国医疗器械行业协会理事单位、山东省医疗器械生产质量规范实施示范企业。 公司以满足客户需求为导向，营销网络覆盖全国所有省、自治区、直辖市。公司将坚持“做再生医学领域领导者”的企业愿景，在改善人民群众生命质量、提升社会医疗健康水平、推动生物医药产业创新发展方面做出积极贡献。 | ||||||||||||||||||||||||
| Main Business | 生物再生材料的研发、生产与销售。 | ||||||||||||||||||||||||
| Legal Representative | 郭焕祥 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 赵丽 | ||||||||||||||||||||||||
| Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
| Auditors | 大信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0535-6971993 | ||||||||||||||||||||||||
| Fax No | 0535-6971993 | ||||||||||||||||||||||||
| Website | www.zhbio.com | ||||||||||||||||||||||||
| ir@zhbio.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 16/05/2017 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.750 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.460 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.938 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.593B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |